• Paediatric proton therapy. Thomas H, Timmermann B. Br J Radiol. 2020 Mar;93(1107):20190601. doi: 10.1259/bjr.20190601. Epub 2019 Sep 19. PMID: 31529979 Review.
  • Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort. Benesch M, Nemes K, Neumayer P, Hasselblatt M, Timmermann B, Bison B, Ebetsberger-Dachs G, Bourdeaut F, Dufour C, Biassoni V, Morales La Madrid A, Entz-Werle N, Laithier V, Quehenberger F, Weis S, Sumerauer D, Siebert R, Bens S, Schneppenheim R, Kool M, Modena P, Fouyssac F, C Frühwald M. Pediatr Blood Cancer. 2020 Jan;67(1):e28022. doi: 10.1002/pbc.28022. Epub 2019 Oct 1.PMID: 31571386
  • Optical range determination of clinical proton beams in water. A comparison with standard measurement methods. Burg JM, Horst F, Wulff J, Timmermann B, Vorwerk H, Zink K. Phys Med. 2020 May;73:197-203. doi: 10.1016/j.ejmp.2020.03.012. Epub 2020 May 4. PMID: 32380438 Mitigation of motion effects in pencil-beam scanning - Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma. Siregar H, Bäumer C, Blanck O, Chan M, Engwall E, Plaude S, Spaan B, Timmermann B, Wulff J. Z Med Phys. 2020 Oct 29:S0939-3889(20)30091-X. doi: 10.1016/j.zemedi.2020.08.001. Online ahead of print. PMID: 33131995

General Information

Professor Timmermann’s research focus is on brain, bone and soft tissue tumors in children and adults, multimodality care in pediatric oncology, quality assurance in radiotherapy, craniospinal axis techniques, late sequelae and quality of life, as well as proton beam therapy. One of her central focuses is the multimodal treatment of children with cancer. Approximately half of all children with cancer can be helped with radiation therapy. Therefore about 1000 children in Germany are irradiated every year – a good reason for her to invest in the knowledge gain and quality assurance of radiation therapy. Her motivation to work in the research area of paediatric oncology particular particle radiotherapy is not to give too much radiation therapy to any child, but also not too little. In this way the best chances of recovery with the lowest risk of side effects can be achieved.

Professor Timmermann is very keen on the promotion of young scientists and the training of ESR. She is highly engaged in qualifying students and (young) professionals in the field of oncology and particle therapy and has already a wide range of experience which she would like to use profitably in the THERADNET project.

Current Position

  • Director of the Clinic for Particle Therapy, Essen University Hospital
  • Medical Director, West German Proton Therapy Center
  • Head of the National Advisory Center “Particle Therapy in Pediatric Oncology in Germany
  • Speaker of the consortium for reference radiotherapy in the German Pediatric Brain Tumor Study Group (HIT-Network)
  • Reference radiation therapist of various interdisciplinary studies (CWS, osteosarcomas, EUROEwing 2008, brain tumor studies of the GPOH, neuroblastoma study, retinoblastoma registry)
  • Director of the ESTRO course “Pediatric Radiation Oncology”
  • Course director of the course “Radiotherapy of childhood cancer” of GPOH and DEGRO
  • Member of faculty of the ESTRO course “Particle Therapy”
  • Member of the executive committee of the PROS
  • Member of the Scientific Review Committee of national and international congresses (PTCOG, ESTRO, SIOP, DEGRO)
  • Examiner for the qualification “proton therapy” of the Bavarian State Medical Association
  • Member of the Certification Commission Module Pediatric Oncology of the German Cancer Society
  • Member of the Board of the Cancer Society NRW e.V.
  • Chairwoman of the Advisory Board “Stiftung Universitätsmedizin Essen” (elect)
  • Member of the Editorial Board of the International Journal of Particle Therapy
  • Member of the Editorial Board “Radiation Oncology”
  • Guest Editor in “Frontiers of Oncology” for the research topic: Proton Therapy in Cancer Treatments: Clinical Evidence and Controversies

Relevant work experience

Since 2014     Full Professor for Radiation Oncology, Particle Therapy, Director of Department for Particle Therapy, Essen University Hospital

2011-2013       Medical Director, WPE, Essen, Germany

2009-2011      Vice Medical Director of the West German Proton Therapy Centre Essen (WPE), Essen, Germany

2007-2013      Adjunct Professor, Department of Radiation Oncology, University of Münster, Germany

2005-2009      Vice Medical Director of the ZPT, PSI, Villigen, Switzerland,

2002-2005      Senior Radiation Oncologist, Head of the Pediatric Program, Center for Proton Beam Therapy (ZPT), Paul Scherrer Institute (PSI), Villigen, Switzerland

2000-2002      Postdoctoral Medical fellow, Department of Radiation Therapy and Radiation Oncology (Prof. Dr. M. Bamberg), University of Tübingen, Germany

1995-2000      Scientific medical staff member, Department of Radiation Therapy and Radiation Oncology (Prof. Dr. M. Bamberg), University of Tübingen, Germany

Professional background

Since 2014     Full Professor for Radiation Oncology, Particle Therapy, Director of the Clinic for Particle Therapy, Essen University Hospital

2012                Call for full Professorship, Radiation Oncology, Particle Therapy, University Duisburg-Essen, Germany

2009                “Fachkunde Protonentherapie” (German authority approval to supervise proton beam therapy)

2007                “Habilitation” in Radiation Oncology (Prof. Dr. N. Willich) / adjunct Professor, Medical Faculty, University of Münster, Germany

2002                Completing specialization in Radiation Oncology

2000                Obtaining MD degree, Faculty of Medicine, University of Tübingen, Germany, supervisor: Prof. M. Bamberg

1995-2002      Specialty training in Radiation Oncology, University of Tübingen, Germany

1994-1995      Residency, Department of Pathology, Asklepios Clinic Barmbek, Hamburg, Germany

1986-1993      Medical school, University of Hamburg, Germany